Literature DB >> 32051752

MiR-34b-5p inhibits cell proliferation, migration and invasion through targeting ARHGAP1 in breast cancer.

Lifeng Dong1, Fangfang Chen1, Yangfan Fan1, Jingpei Long1.   

Abstract

This study aim at investigating the function of microRNA (miR)-34b-5p in breast cancer prognosis and development. qRT-PCR was used for miR-34b-5p expression examination in breast cancer samples. CCK8, immunohistochemistry, scratch wound healing, transwell assays were performed for cell experiments. Subcutaneously implanted tumor model was carried out for animal experiment. Western blot was conducted for protein expression detection. Bioinformatics analysis was performed for exploring the underlying mechanism. MiR-34b-5p expression was down-regulated in breast cancer samples and cells, and miR-34d-5p could inhibit cell viability, migration and invasion also delay tumor growth in vivo. Low miR-34b-5p expression showed a bad prognosis of breast cancer patients. MiR-34b-5p functioned as a tumor suppressor by targeting ARHGAP1, and ARHGAP1 knockdown could reverse the effect of miR-34b-5p inhibitor on breast cancer cells. MiR-34b-5p exerts an anti-tumorigenesis role in breast cancer cells by targeting ARHGAP1, which is profitable for the breast cancer diagnosis and molecular treatment. AJTR
Copyright © 2020.

Entities:  

Keywords:  ARHGAP1; breast cancer; invasion; microRNA-34b-5p; tumor growth

Year:  2020        PMID: 32051752      PMCID: PMC7013215     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   4.060


  27 in total

1.  Epigenetic modification in 4T1 mouse breast cancer model by artificial light at night and melatonin - the role of DNA-methyltransferase.

Authors:  Sahar Agbaria; Abraham Haim; Fuad Fares; Abed E Zubidat
Journal:  Chronobiol Int       Date:  2019-02-12       Impact factor: 2.877

2.  MiRNA-107 inhibits proliferation and migration by targeting CDK8 in breast cancer.

Authors:  Xiao-Yu Li; Qi-Feng Luo; Chuan-Kui Wei; Deng-Feng Li; Jia Li; Lin Fang
Journal:  Int J Clin Exp Med       Date:  2014-01-15

3.  Clinicopathological Significance of the Proliferation Markers Ki67, RacGAP1, and Topoisomerase 2 Alpha in Breast Cancer.

Authors:  Sevinç Şahin; İpek Işık Gönül; Aslı Çakır; Selda Seçkin; Ömer Uluoğlu
Journal:  Int J Surg Pathol       Date:  2016-06-09       Impact factor: 1.271

4.  Tumor-suppressive miRNA-135a inhibits breast cancer cell proliferation by targeting ELK1 and ELK3 oncogenes.

Authors:  Akhlaq Ahmad; Weijie Zhang; Mingming Wu; Sheng Tan; Tao Zhu
Journal:  Genes Genomics       Date:  2017-10-19       Impact factor: 1.839

5.  miR-130b directly targets ARHGAP1 to drive activation of a metastatic CDC42-PAK1-AP1 positive feedback loop in Ewing sarcoma.

Authors:  Laura Satterfield; Ryan Shuck; Lyazat Kurenbekova; Wendy Allen-Rhoades; Dean Edwards; Shixia Huang; Kimal Rajapakshe; Cristian Coarfa; Lawrence A Donehower; Jason T Yustein
Journal:  Int J Cancer       Date:  2017-08-08       Impact factor: 7.396

6.  Epigenetic regulation of microRNA genes and the role of miR-34b in cell invasion and motility in human melanoma.

Authors:  Joseph Mazar; Divya Khaitan; Dan DeBlasio; Cuncong Zhong; Subramaniam S Govindarajan; Sharmila Kopanathi; Shaojie Zhang; Animesh Ray; Ranjan J Perera
Journal:  PLoS One       Date:  2011-09-19       Impact factor: 3.240

7.  Cancer-secreted hsa-miR-940 induces an osteoblastic phenotype in the bone metastatic microenvironment via targeting ARHGAP1 and FAM134A.

Authors:  Kyoko Hashimoto; Hiroki Ochi; Satoko Sunamura; Nobuyoshi Kosaka; Yo Mabuchi; Toru Fukuda; Kenta Yao; Hiroaki Kanda; Keisuke Ae; Atsushi Okawa; Chihiro Akazawa; Takahiro Ochiya; Mitsuru Futakuchi; Shu Takeda; Shingo Sato
Journal:  Proc Natl Acad Sci U S A       Date:  2018-02-12       Impact factor: 11.205

8.  MiRNA-26b inhibits proliferation by targeting PTGS2 in breast cancer.

Authors:  Jia Li; Xiangjie Kong; Junfeng Zhang; Qifeng Luo; Xiaoyu Li; Lin Fang
Journal:  Cancer Cell Int       Date:  2013-02-01       Impact factor: 5.722

9.  miR-34b-5p inhibition attenuates lung inflammation and apoptosis in an LPS-induced acute lung injury mouse model by targeting progranulin.

Authors:  Wang Xie; Qingchun Lu; Kailing Wang; Jingjing Lu; Xia Gu; Dongyi Zhu; Fanglei Liu; Zhongliang Guo
Journal:  J Cell Physiol       Date:  2018-03-25       Impact factor: 6.384

10.  MiR-34b/c-5p and the neurokinin-1 receptor regulate breast cancer cell proliferation and apoptosis.

Authors:  Lufang Zhang; Lushan Wang; Dong Dong; Zhiyong Wang; Wei Ji; Man Yu; Fei Zhang; Ruifang Niu; Yunli Zhou
Journal:  Cell Prolif       Date:  2018-10-17       Impact factor: 6.831

View more
  4 in total

1.  Exploring biomarkers and therapeutic targets for pressure overload induced heart failure based on microarray data.

Authors:  Yongli He; Zhe Feng; Jianjun Lu; Rui Wang; Cheng Huang; Yingling Zhou
Journal:  Cardiovasc Diagn Ther       Date:  2020-10

Review 2.  Fixing the GAP: The role of RhoGAPs in cancer.

Authors:  Gabriel Kreider-Letterman; Nicole M Carr; Rafael Garcia-Mata
Journal:  Eur J Cell Biol       Date:  2022-02-10       Impact factor: 6.020

3.  Berberine Suppresses Mice Depression Behaviors and Promotes Hippocampal Neurons Growth Through Regulating the miR-34b-5p/miR-470-5p/BDNF Axis.

Authors:  Yuhua Zhan; Jiyang Han; Jing Xia; Xumei Wang
Journal:  Neuropsychiatr Dis Treat       Date:  2021-02-22       Impact factor: 2.570

4.  NR2F1-AS1 Acts as an Oncogene in Breast Cancer by Competitively Binding with miR-641.

Authors:  Yan Zhong; Weiwei Zeng
Journal:  J Healthc Eng       Date:  2022-01-17       Impact factor: 2.682

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.